| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e96496a9949403e2af2ca913e65bfec |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-38 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-22 |
| filingDate |
2009-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ec5a88b190e4f995b4ac45eaa3c3768
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd8246555f6ecfd7a9e261c4e7fc5f7a |
| publicationDate |
2010-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2010137425-A1 |
| titleOfInvention |
Inhibition and treatment of prostate cancer metastasis |
| abstract |
The present invention provides compounds and methods of inhibiting and treating metastatic prostate cancer. The compounds include MEK4 inhibitors. In another aspect the invention provides methods of identifying inhibitors of metastatic prostate cancer by screening for inhibitors of MEK4. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11639340-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9771625-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016159763-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10561663-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11738095-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10125099-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9675620-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020163637-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10414743-B2 |
| priorityDate |
2008-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |